Adopting new pneumococcal vaccines into pediatric practice
November 18, 2023
2 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
”
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio
NEW YORK — In this video from the Infectious Diseases in Children Symposium, Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses the importance of pediatricians adopting new pneumococcal vaccines into practice to optimize patient coverage.
The CDC recommends that all children aged younger than 5 years receive either a 15-valent or 20-valent pneumococcal vaccine, both of which were approved for children in the last 17 months.
“What’s really exciting is that there are universal pneumococcal vaccines that are now in development, which would give us the opportunity to protect individuals against all pneumococcal serotypes that may be emerging,” said Tan, attending physician in pediatric infectious diseases at Lurie Children’s Hospital of Chicago and professor of pediatrics at Northwestern University Feinberg School of Medicine.
References:
CDC. Pneumococcal vaccine recommendations. https://www.cdc.gov/vaccines/vpd/pneumo/hcp/recommendations.html. Last reviewed Sept. 21, 2023. Accessed Nov. 18, 2023.
Tan TQ. Pneumococcal conjugate vaccines — more numbers, more protection. Presented at: Infectious Diseases in Children Symposium; Nov. 18-19, 2023; New York.
Published by:
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
”
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio
